Seeking Alpha

Pozen (POZN) -24.7% premarket after the biotech company discloses the FDA requested additional...

Pozen (POZN) -24.7% premarket after the biotech company discloses the FDA requested additional data for its PA32540 fixed-dose "safer aspirin" product which may delay submission of its new drug application.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|